FT.com / Search

1-10 of 723 results for Novartis AG

Sort by:

Relevance
Date

January 26, 2010
Vasella to drop CEO role at Novartis
...executive who has steered the rise of Novartis for more than a decade, is to step down...recent indication of a change of heart. Novartis also said it would give shareholders a future...governance critics.The changes came as Novartis reported strong sales and earnings for... By Haig Simonian in Basel
January 26, 2010
Dr Vasella prescribes good governance pill at Novartis
...Switzerland by turning up at the annual Novartis press conference sporting a fine beard...main Swiss pharmaceutical rival in which Novartis holds a large minority stake. At Roche...separate chairmen and chief executives. So Novartis probably felt it was time to adapt its... By Paul Betts and Sundeep Tucker
January 17, 2010
Novartis spurs investor fight for equality
...Alcon’s minority shareholders to block Novartis’ $39bn merger has highlighted the...for the same stock during takeovers. Novartis, which acquired a 25 per cent stake...care company to 77 per cent. However, Novartis has offered $11.2bn to buy out the... By Lina Saigol and Kate Burgess
January 26, 2010
Novartis
...chief executive of the Swiss drugmaker Novartis, has unexpectedly relinquished his chief...chairmanship. The timing is canny. On Tuesday Novartis also announced an 8 per cent jump in full...per cent of sales last year. Although Novartis’ patent does not run out for two years, the...
January 26, 2010
Rapid rise of outsider to head Novartis
The appointment of Joe Jimenez as chief executive of Novartis heralds the unusually rapid rise of an outsider to the top...ran the company’s European operations until he joined Novartis as head of its consumer health business only in 2007... By Andrew Jack in London
January 26, 2010
Novartis in stealthy pursuit of change
...survive as much as a symbolic moment for Novartis. While many recently appointed pharmaceutical...held the combined role of chairman at Novartis for 11 years following its formation...standing shareholder pressure for change at Novartis to improve performance, broader corporate... By Andrew Jack and Haig Simonian
January 4, 2010
Novartis strengthens position in eye care
Novartis on Monday underlined its determination...Texas, but legally a Swiss company, with Novartis’s Ciba Vision subsidiary will create...sales of $8.5bn. As in April 2008 when Novartis announced its acquisition of an initial... By Haig Simonian
January 5, 2010
Novartis overwrite
Novartis, the Swiss pharmaceuticals group, on...majority owner, would use the $28.1bn Novartis is paying for its remaining 52 per cent...other possible targets. Daniel Vasella, Novartis’s chairman and chief executive, justified... By Haig Simonian in Zurich
January 11, 2010
Alcon to line up Novartis bid defence
...care business’ minority investors by Novartis as part of a $50bn takeover. Thomas...ahead of a formal public response to Novartis to be issued within the next two weeks...lawsuits in Texas and New York to challenge Novartis’s offer, criticising both its price... By Andrew Jack in London and Haig Simonian in Zurich
January 4, 2010
Novartis in focus as bourses lifted
...the pharmaceuticals sector brought Novartis into focus on Monday, as European shares began the new year strongly. Novartis announced it would buy out majority...previously agreed transaction. Shares in Novartis fell 2.6 per cent to SFr55.05... By Courtney Weaver